Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 13, 2023HaematologicaOpen Access

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAðalbjörg Ýr SigurbergsdóttirUniversity of IcelandSRSæmundur RögnvaldssonReykjavík UniversitySÞSigrún ÞorsteinsdóttirUniversity of Iceland

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sigurbergsdóttir et al. (2023) studied this question.

synapsesocial.com/papers/6a62f0ec4f5ef41b946a86f7https://doi.org/10.3324/haematol.2023.283191
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases2021 · 2,553 citations
  2. 2Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Laboratory and Genetic Testing (An Evidence‐Based Review)2009 · 141 citations
  3. 3Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders2008 · 223 citations
  4. 4A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance2002 · 1,486 citations
  5. 5Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study2011 · 146 citations